Clinical Trial Update: Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months) [Phase 4]

View source ↗

Summary

This Phase 4 trial assesses the long-term efficacy and safety of once-daily atomoxetine hydrochloride in adults with attention deficit hyperactivity disorder ov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: ADHD | Phase 4 | Status: COMPLETED